Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Background/Aims Hepatic damage during transarterial chemoembolization (TACE) is a critical complication in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Apart from its role in preventing HBV reactivation, there is some evidence for the benefits of preemptive antiviral...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Format: Artigo
Idioma:Inglês
Publicat: Korean Association for the Study of the Liver 2016-12-01
Col·lecció:Clinical and Molecular Hepatology
Matèries:
Acute hepatic decompensation
Chronic hepatitis B
Hepatocellular carcinoma
Transarterial chemoembolization
Preemptive antiviral treatment
Accés en línia:http://e-cmh.org/upload/pdf/cmh-2016-0054.pdf
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars